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Angiogenesisa b s t r a c t
Pancreatic islet transplantation is a promising treatment for type 1 diabetes. However, viability and
functionality of the islets after transplantation are limited due to loss of integrity and destruction of blood
vessel networks. Thus, it is important to provide a proper mechanically and biologically supportive envi-
ronment for enhancing both in vitro islet culture and transplantation efficiency. Here, we demonstrate
that heparin mimetic peptide amphiphile (HM-PA) nanofibrous network is a promising platform for these
purposes. The islets cultured with peptide nanofiber gel containing growth factors exhibited a similar
glucose stimulation index as that of the freshly isolated islets even after 7 days. After transplantation
of islets to STZ-induced diabetic rats, 28 day-long monitoring displayed that islets that were transplanted
in HM-PA nanofiber gels maintained better blood glucose levels at normal levels compared to the only
islet transplantation group. In addition, intraperitoneal glucose tolerance test revealed that animals that
were transplanted with islets within peptide gels showed a similar pattern with the healthy control
group. Histological assessment showed that islets transplanted within peptide nanofiber gels demon-
strated better islet integrity due to increased blood vessel density. This work demonstrates that using
the HM-PA nanofiber gel platform enhances the islets function and islet transplantation efficiency both
in vitro and in vivo.
 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction of Langerhans, resulting in insulin deficiency and hyperglycemiaDiabetes mellitus is one of the most common diseases in the
world and causes more than 200,000 deaths each year in the
United States [1]. There are approximately 177 million diabetic
patients worldwide and this number is expected to double by
2025 [2]. Diabetes is associated with serious complications, includ-
ing cardiovascular, renal, ophthalmic, neurological, cerebrovascu-
lar, and peripheral vascular diseases [3–8].
Type 1 diabetes (T1D) is a chronic autoimmune disease and
involves the destruction of or damage to the b-cells in the islets[9]. Since the discovery of the insulin hormone in 1921, insulin
treatment has been the standard therapeutic approach to treat
T1D. However, because of the fluctuation of the blood glucose
levels of the patients throughout the day, insulin therapy alone
was found to be insufficient for curing the disease, as acute mor-
bidity and mortality as well as a series of chronic complications
were observed after insulin treatment [10,11]. Although improve-
ments in insulin delivery systems were proposed to provide strict
control on blood glucose levels, there are several limitations
including poor patient compliance, risk of hypoglycemia and com-
plications caused by using devices for insulin delivery [11]. Islet
transplantation has been used as a treatment for T1D to improve
glycemic control in patients and rescue them from daily insulin
injection [12]. This method is as effective as whole pancreas trans-
plantation and less invasive [11]. Although it is a promising
method, there are several limitations such as insufficient number
of donors and decreased islet viability during and after isolation
[13]. Cellular stress and disruption of islets’ original integrity
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Pancreatic islets tend to form clusters and in these clusters, cells,
which exist in the core of the islet die due to decreased oxygen
and nutrient transport. Normally, islets have extensive intra-islet
vasculature to overcome these problems [16]. This vasculature is
damaged during the isolation procedure, and the damaged
microvasculature only regenerates after 10–14 days following the
transplantation [17–20]. However, low diffusion of nutrients and
oxygen leads to deterioration of cells [21] including b-cells and
leads to hypoxia and death [22].
In the initial few days of transplantation using alternative trans-
plantation sites, supportive scaffolds and minimizing the immuno-
logical responses are being investigated in order to increase the
islet viability and consequently long term normoglycemia. Until
now, several alternative transplantation sites such as liver through
the portal venous circulation [23], spleen, kidney [24], testis [25],
anterior chamber of the eye [26], and greater omentum [27] have
been tested to find an effective and less invasive surgical procedure
for patient safety. Due to its self-healing potential, omentum was
also used for revascularization of brain [28] and heart [29], and
regeneration of spinal cord [30]. It has several advantages com-
pared to other transplantation sites which are (1) large transplan-
tation area, (2) less direct contact with blood that prevents instant
immunological response and higher blood pressure, and (3) not
being a vital organ. On the other hand, it requires more islets for
transplantation and enhanced blood vessel formation for trans-
plantation efficiency [31].
During the islet isolation procedure, enzyme treatment disrupts
islet–matrix interactions, which results in extracellular matrix
(ECM) degradation and cell apoptosis [15,32]. Supporting the islets
in in vitro conditions with matrices that contain ECM components
such as collagen and fibrin increases viability of the islets [33–35]
and it shows the importance of scaffolds in providing an ECM-
mimetic environment for islets.
In this study, peptide amphiphile (PA) nanofibers were used as a
bioactive scaffold for islet transplantation. The PA molecules self-
assemble into nanofibers due to intermolecular hydrogen bonding,
electrostatic interaction between charged amino acids, and
hydrophobic interactions [36,37]. PA nanofibers form a 3D network
in aqueous environment, which resemble natural ECM and this net-
work can be enriched with specific bioactive sequences to modulate
cell-material interactions. PA nanofibers have previously been used
as functional scaffolds for bone [38,39], neural [40], and cornea [41]
regeneration and can also be used as drug delivery agents [42].
Here, heparin mimetic peptide amphiphile (HM-PA) nanofibers
were used as a new therapeutic approach for type 1 diabetes to
enhance the function of pancreatic islets and to improve the islet
transplantation efficiency. The HM-PA nanofibers induce capil-
lary-like structure formation of endothelial cells in vitro and the
PA scaffold applied with vascular endothelial growth factor
(VEGF) and fibroblast growth factor 2 (FGF-2), induce angiogenesis,
in cornea in vivo [43]. The HM-PA provides an ECM like
environment to enhance angiogenesis, which in turn enhances islet
viability and functionality both in vitro and in vivo.2. Materials and methods
2.1. Materials
9-Fluorenylmethoxycarbonyl (Fmoc) and other protected
amino acids, lauric acid, [4-[a-(20,40-dimethoxyphenyl)Fmoc-
amino methyl]phenoxy] acetomidonorleucyl-MBHA resin (Rink
amide MBHA resin), 2-(1H-Benzotriazol-1-yl)-1,1,3,3-tetramethy-
luronium hexafluorophosphate (HBTU), and diisopropylethy-
lamine (DIEA) were purchased from Merck. ABCR Collagenase Vand Streptozotocin (STZ) were purchased from Sigma–Aldrich.
RPMI 1640, Hanks Balanced Salt Solution (HBSS), Fetal Bovine
Serum (FBS), penicillin/streptomycin/amphotericin B and L-glu-
tamine were purchased from Lonza. Biocoll 1100 and Biocoll
1077 were purchased Biochrom. Rat–Mouse Insulin Assay and cell
inserts were purchased from Milipore. VEGF was purchased from
R&D and human FGF-2 from Sigma–Aldrich. All chemicals were
used as provided.
2.2. Synthesis and purification of peptide amphiphile molecules
Peptide molecules were synthesized by solid-phase Fmoc pep-
tide synthesis method. HM-PA (Lauryl-VVAGEGD(K-pbs)S-Am)
and K-PA (Lauryl-VVAGK-Am) were constructed on Rink Amide
MBHA resin via the solid phase peptide synthesis method.
Coupling was performed with 1 equivalent of MBHA resin, 2 equiv-
alent of Fmoc protected group amino acid, 1.95 equivalent of HBTU
and 3 equivalent of N,N-diisopropylethylamine (DIEA) for 2 h.
Fmoc removal was performed with 20% piperidine/dimethylfor-
mamide solution (DMF) for 20 min. 10% acetic anhydride/DMF
was used as blocking agent for the remaining free amine groups
after coupling. The resin was washed three times with DMF,
dichloromethane (DCM) and DMF, respectively. In order to synthe-
size HM-PA, sulfobenzoic acid was added to the side chain of
lysine. Before this process, 4-methyltrityl (MTT) group, which pro-
vides side chain protection for lysine, was removed by a trifluo-
roacetic acid (TFA)/triisopropylsilane (TIS)/H2O/DCM mixture
(5:2.5:2.5:90 ratio) for 5 min. Then, peptide cleavage was per-
formed with 95:2.5:2.5 TFA:TIS:H2O for 2 h at room temperature.
After cleavage reaction, PA molecules were collected in a clean
round bottomed flask and DCM wash was performed several times.
Excess TFA was removed by a rotary-evaporator. After evaporation,
ice-cold diethyl ether was added into the PA solution and the
resulting white precipitate was dried under vacuum. PAs were
characterized by liquid chromatography and mass spectrometry
(LC–MS). Mass spectrum was obtained with Agilent 1200 LC–MS
equipped with Agilent 6530 Q-TOF with an ESI source and
Zorbax Extend-C18 2.1  50 mm column for basic conditions and
Zorbax SB-C8 4.6 mm  100 mm column for acidic conditions. A
gradient of water (0.1% formic acid or 0.1% NH4OH) and acetoni-
trile (0.1% formic acid or 0.1% NH4OH) was used. Purification of
PAs was performed by using a reverse phase preparative high-
performance liquid chromatography (HPLC) (Agilent 1200 series)
system by using Zorbax Extend-C18 21.2  150 mm column.
2.3. Physical, mechanical and chemical characterization of self-
assembled nanofiber network
2.3.1. Transmission electron microscopy (TEM)
The morphology of self assembled PA nanostructure was char-
acterized by transmission electron microscopy (TEM). 10 lL of
the PA solution was deposited on a Lacey carbon-coated 300-mesh
copper grid and incubated for 3 min. Excess solution was removed
by tissue paper and the sample was negatively stained with 2 wt%
uranyl acetate and dried at room temperature. Images were visual-
ized by a FEI Tecnai G2 F30 transmission electron microscope.
2.3.2. Atomic force microscopy (AFM)
PA solutions that were dissolved in water were prepared by
mixing 0.05 wt% HM-PA with K-PA at 1:1 volume ratio on a silicon
wafer. After the sample was dried at room temperature for 30 min,
AFM images were taken via MFP-30 Asylum Research in tapping
mode using the appropriate cantilever. All images were taken with
1.0–1.5 Hz scan rate and 1024  512 resolution. Tips with
resonance frequency of 246 kHz were used.
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The three dimensional nanofibrous network of PA molecules
was investigated using scanning electron microscopy (SEM). 1%
w/v PA solutions were mixed with the volume ratio of 1:1 to
achieve gel formation. Gels were incubated for 15 min for matura-
tion and dehydrated gradually with increasing concentrations of
ethanol for 2 min each. Samples were dried in a critical point dryer
(Tousimis, Autosamdri-815B, Series C critical point dryer) and
coated with 8 nm of Au/Pd. SEM imaging of the nanofiber networks
was taken with an FEI Quanta 200 FEG scanning electron
microscope under high vacuum.
2.3.4. Circular dichroism (CD)
Secondary structure of PA molecules was investigated by CD
analysis using JASCO J815 CD spectrapolarimetry. PA solutions
were dissolved in deionized water at a concentration of 0.01%
w/v and pH was adjusted to 7.4. The CD spectra of HM-PA, K-PA
and HM-PA/K-PA (1:1 volume ratio) were obtained from scanning
at 190 nm to 300 nm using a digital integration time of 1 s, a band
width of 1 nm and with standard sensitivity.
2.4. Animals
In vivo experiments were carried out with 3 month old Wistar
male rats for both syngeneic islet donors and islet recipients.
Rats were maintained on ad libitum access to water and nutrition
in a 12–12 h light–dark cycle except the day before transplanta-
tion. All procedures regarding animals were approved by
Institutional Animal Care and Use Committee of Diskapi Yildirim
Beyazit Training and Research Hospital.
2.5. Islet isolation and culture
Cell culture studies were carried out with isolated syngeneic
primary pancreatic islets. The pancreas islet isolation was done
according to methods modified from other studies [44–46].
Briefly, rats were anesthetized by an intraperitoneal injection of
ketamycin (80 mg/kg) and xylazine (20 mg/kg). Then midline
laparotomy was performed, and the common bile duct was cannu-
lated. The 1 mg/mL concentration of collagenase Type V enzyme
solution was prepared in cold Hanks’ Balanced Salt Solution.
Following the injection of 7 mL of cold collagenase (Type V,
1 mg/mL) into the duct with a 22G cannula, the distended pan-
creas was removed and subjected to stationary digestion for
18 min at 37 C. At the end of the incubation time, cold HBSS sup-
plemented with 10% FBS, 1% L-glutamine and 1% Penicillin–
Streptomycin–Amphotericin B was added for inhibition of enzyme
activity and washing. After the digested pancreas was centrifuged
for 3 min at 300g with slow brake, the supernatant was removed
gently. The pellet suspension was filtered by a steel sieve of
450 lm to remove islets from undigested tissue. Subsequently,
the islets were purified by using Biocoll 1100 (1100 g/mL),
Biocoll 1077 (1077 g/mL) and RPMI 1640 to create a discontinuous
gradient and were centrifuged for 20 min at 1100g with slow
brake. After purification, the islets were washed with RPMI 1640
supplemented with 10% FBS, 1% L-Glutamine and 1% Penicillin–
Streptomycin–Amphotericin B. Islets were counted and picked
up under an optical microscope via the handpick method. Islet
cells were cultured with 10% FBS 1% penicillin/streptomycin/
amphotericin B and 1% L-glutamine supplemented RPMI 1640 at
37 C under the humidified atmosphere containing 5% CO2
incubator.
2.5.1. Pancreatic islet viability
Viability was assessed by normalizing to DNA content using
Alamar Blue Assay (Invitrogen) and FluoReporter BlueFluorometric dsDNA Quantitation Kit (Invitrogen) by using 50
islets sized between 100–200 lm. After incubating islets for 24 h,
six experimental conditions were constituted: (1) media only as
a control group; (2) media with HM-PA and K-PA; (3) media with
HM-PA; (4) media with VEGF and FGF-2; (5) media with HM-PA,
VEGF and FGF2; (6) media with HM-PA, K-PA, VEGF and FGF2.
RPMI 1640 with 1% L-glutamine and 1% penicillin/streptomycin/
amphotericin B was used as culture media. PA solutions were
added to the media at the final concentration of 0.1% w/v HM-PA
and 0.1% w/v K-PA (1:1 volume ratio) and the growth factor
amounts were determined as 100 ng. The experiment was per-
formed at days 1, 3 and 7 (n = 4). Before starting the Alamar Blue
Assay, islets were collected and transferred into tissue culture
inserts (8 lm pore size, Millicell). Alamar Blue stock solution was
diluted to 1:10 with the culture medium and incubated with islets
at 37 C with 5% CO2 for 4 h. At the end of the 4 h, absorbance was
monitored at 570 nm. The inserts with islets were kept at 80 C
for DNA quantification. In order to quantify DNA amounts, islet
samples were thawed at room temperature and 200 lL of ddH2O
was added into each well. Plates were incubated in a humidified
incubator (37 C, 5% CO2) for 1 h, and then frozen at 80 C for
2 h to disrupt the cell membrane. Afterward, cells were thawed
at room temperature again and Hoechst 33258 dye in TNE
(10 mM Tris, 2 M NaCl, 1 mM EDTA, pH 7.4, containing 2 mM
sodium azide) was added into wells with the volume of
200 lL/well. 200 lL from this solution was transferred to a 96 well
plate and fluorescence was read at 360 nm and 460 nm by a micro-
plate reader. The ratio of viability and DNA was calculated by
dividing the Alamar Blue Assay results by DNA Assay results.
2.5.2. Glucose stimulated insulin release
Islets were handpicked to have a size distribution of
150–200 lm in diameter, and cultured (10 islets each well) on
tissue culture inserts (8 lm pore size) (Millipore, Billerica, MA)
for 24 h before they were processed for evaluation of glucose stim-
ulated insulin release. Islets were washed with RPMI 1640 medium
containing 3.3 mM glucose for 30 min. Following the wash, islets
were sequentially incubated in 3.3 mM glucose and 16.7 mM glu-
cose containing media at 37 C, 5% CO2 for 1 h. Before medium
changes, media were collected and stored at 20 C. Experiments
were carried out on days 1, 3 and 7. Glucose stimulation assay
was performed via Rat/Mouse Insulin 96 Well Plate Assay, ELISA
Kit, Millipore as instructed by the manufacturer. Insulin release
was quantified as a ratio of high glucose to low glucose state and
presented as the stimulation index.
2.6. Transplantation
10 days before transplantation, 220 mg/kg STZ which was pre-
sent in the citrate buffer (0.1 M, pH 4.5) was injected into rats
intraperitoneally to induce diabetes. Blood glucose levels of the
rats were measured using an On Call Advanced Blood Glucose
Monitoring System (Acon Laboratories Inc., CA USA). Blood glucose
levels of rats were measured at days 5 and 3 before transplanta-
tion, and only animals with blood glucose levels of >300 mg/dL
at both days were used for transplantation experiments. 2000
islets were transplanted into the omentum of each rat. Isolated
islets with a minimal volume of medium were mixed with
HM-PA and then, gelation was triggered with the addition of
K-PA. The final concentrations of PA solutions in scaffold were 1%
w/v HM-PA and 1% w/v K-PA at 1:1 volume ratio.
An intraperitoneal injection of ketamycin (80 mg/kg) and xyla-
zine (10 mg/kg) was used as anesthetic agents. The abdominal
region of rats was shaved and sterilized with antiseptic solution
(BATTICON solution, Adeka, Turkey). A greater omentum was
reached by a lower abdominal incision and it was spread onto a
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omentum, and the omentum was sewed with 3.0 PGLA (90% gly-
colide and 10% L-lactide) surgical sutures as a pouch model. After
the procedure, animals were administered 1000 mg/kg cefazolin
(Mustafa Nevzat, Turkey) subcutaneously. Recipient rats were clas-
sified as (i) control (untreated), (n = 7), (ii) sham (n = 7), (iii) PA
(n = 7), (iv) islet (n = 7), (v) PA + islet groups (n = 7).
PA gels without islets were transplanted to serve as negative
control (PA group). A sham group, comprising animals that have
undergone surgery but did not receive PA or islet transplantation,
was also included in the study. Animal omentum was sewed as a
pouch model. Healthy rats showing normal blood glucose levels
were used as a positive control. Animals in the islet group were
transplanted with only islets but no PA gel. Rats were allowed to
eat and drink freely after the operation and routine controls were
done throughout the study for infection.2.7. Scaffold function assessment
After transplantation, non-fasting blood glucose levels and
weight of the animals were measured three times a week for
28 days. The graft was considered to be functional only if the blood
glucose levels of the recipients were less than 300 mg/dL.
Intraperitoneal glucose tolerance test (IPGTT) was performed at
28 days after transplantation to measure the effect of glucose chal-
lenges. After fasting overnight, rats were injected with glucose
solution (2 g/kg) intraperitoneally after intraperitoneal injection
of anesthetic agents; ketamycin (80 mg/kg) and xylazine (10 mg/
kg). Blood glucose levels were measured from the tail vein at the
baseline (before injection), 5, 10, 15, 30, 60, 90 and 120 min after
injection.2.8. Histological analysis
At the end of 28 days, rats were anesthetized and transcardially
perfused with saline and formalin, respectively. Omentum and
pancreas tissues were collected and fixed in formalin for approxi-
mately 18 h before being embedded into paraffin. Tissues were
sectioned with a Leica microtome at 5 lm thickness. Sections were
deparaffinized in xylene and rehydrated in serial ethanol series for
hematoxylin & eosin (H&E) staining and Masson’s trichrome stain-
ing according to the standard protocol. For immunohistochemistry
experiments, sections were stained with anti-insulin (1:500; Sigma
I2018, clone K36AC10), anti-macrophages/monocytes (1:300;
Millipore, MAB1435, clone ED-1) and anti-von Willebrand Factor
(1:200; Abcam, ab6994) antibodies. After primary antibody stain-
ing, horseradish peroxidase conjugated goat anti-mouse secondary
antibody (1:500; Millipore) was used followed by 3,30-di-
aminobenzidine (DAB) staining. All samples were mounted onto
glass slides using xylene based mounting medium. Digital images
were acquired via Zeiss Axio Scope A1. For vascular density quan-
tification, each paraffin-embedded omentum tissue was serially
sectioned and 5 matching slides were selected from each tissue
for quantification with approximately 100 lm intervals. Images
were acquired by using a 20 objective.2.9. Statistical analysis
Statistical analyses were performed using two-way ANOVA or
one-way ANOVA with Bonferonni multiple comparison test. The
level of significance was set at p < 0.05 (*p < 0.05; **p < 0.01;
***p < 0.001). Error bars indicate standard error of mean.3. Results
3.1. Heparin mimetic PA molecules self-assemble into nanofibers
The HM-PA was functionalized with bioactive chemical groups
to mimic heparin structure and function (Fig. 1Ai) [43]. Non-bioac-
tive positively charged K-PA was synthesized in order to induce
nanofiber formation through charge neutralization after mixing
with HM-PA (Fig. 1Aii). All peptide molecules were characterized
by liquid chromatography–mass spectrometry (LC–MS) and puri-
fied by preparative HPLC (Figs. S1 and S2). b-Sheet-driven nanofi-
ber elongation was provided via the VVAG motif and analyzed by
circular dichroism (CD) spectroscopy. CD results showed that b-
sheet structure dominates the HM-PA/K-PA mixture with a nega-
tive band at 218 nm and a positive band at 195 nm (Fig. 1B).
SEM image demonstrated the formation of a porous nanofiber net-
work when HM-PA and K-PA were mixed (Fig. 1C). AFM and TEM
images of PA molecules revealed that nanofibers were uniform in
width and were c. 20–30 nm in diameter (Fig. 1D and E).3.2. HM-PA improves function of islets in vitro
A viability analysis was performed to investigate the effect of
HM-PA on pancreatic islets. Viability of cultured islets sized
between 100 and 200 lm in diameter was determined over a 7-
day period using Alamar Blue assay. In our previous study, HM-
PA was shown to have a high binding affinity to VEGF, and FGF-2
[47]. Since FBS contains high amounts of growth factors [48], eval-
uation of islet viability and function was performed in serum-free
conditions. One hundred ng of FGF-2 and VEGF were added to the
culture media where indicated, in order to assess the effect of
growth factor supplementation. During 7 days of culture, although
islets tended to cluster in other groups, islets cultured with HM-
PA/K-PA nanofibers did not form clusters (Fig. 2). Viability mea-
surements indicated that HM-PA/K-PA combinations with and
without growth factors showed higher viability at day 1 and day
3 (Fig. 2B). However, day 7 results were similar between all exper-
imental groups.
It is known that increased cellular viability or activity does not
indicate enhanced functionality because of the tendency of islets to
lose their insulin release capabilities [49]. Thus, insulin release
capacities of cultured islets in response to low versus high glucose
concentrations were measured with an ultrasensitive rat insulin
ELISA (Fig. 3). After 1 day of culture, HM-PA and the combination
of HM-PA and growth factors had 5.7 (p < 0.001) and 4.9
(p < 0.01) times greater glucose stimulation indices (GSI), respec-
tively, compared to the freshly isolated islets (Fig. 3A). At day 3,
though all experimental groups displayed a decreased value of
GSI compared to day 1, islets cultured with HM-PA/K-PA and GFs
had the highest GSI (not statistically significant) (Fig. 3B).
However, after 7 days, islets cultured with HM-PA/K-PA and GFs
showed a GSI of 0.98 which was similar to freshly isolated islets
(1.25) (Fig. 3C).3.3. Transplantation within bioactive PA scaffold improves glucose
responsiveness of the transplanted islets
Islets with or without PA gel were transplanted into the omen-
tum of STZ-induced diabetic rats under general anesthesia. For
transplantation, the omentum was reached through the abdominal
cavity with a small incision. Islets with or without the PA gel scaf-
fold were placed onto it, and finally they were sewed together as a
pouch (Fig. 4A–D). No complications were observed during and
after the surgery. Blood glucose levels of recipient rats (n = 7) are
Fig. 1. (A) Chemical structures of peptide amphiphiles used in this study: (i) HM-PA, and (ii) K-PA. (B) Circular dichroism spectra of the peptide amphiphile molecules. The PA
nanofibers showed characteristic b-sheet structure at physiological pH. (C–E) Characterization of peptide amphiphile nanofiber and scaffolds at pH 7.4 by using: (C) Scanning
electron microscopy, (D) transmission electron microscopy, and (E) atomic force microscopy. Scale bars are 5 lm (C) and 50 nm (D).
Fig. 2. Morphology of the islets seeded on different PA hydrogels with or without growth factor (GF) at day 7 (A). Viability analysis of the islets seeded on different PA
hydrogels with or without growth factor (GF) by using the Alamar blue assay at day 1, day 3 and day 7 (B). Scale bars are 100 lm. [GF = VEGF + FGF-2].
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fold, 2 out of 7 recipients maintained normal glucose levels and 4
out of 7 had blood glucose levels less than 270 mg/dL over the
course of 28 days. ‘‘Only islets’’ group showed higher blood glucose
levels than ‘‘islets with PA scaffold’’ group. Weight of the animalsin all experimental groups did not show a significant change dur-
ing 28 days (Fig. S3).
To investigate the glucose responsiveness of animals trans-
planted with islets and the PA scaffold, we performed the intraperi-
toneal glucose tolerance test (Fig. 5B). The blood glucose level was
Fig. 3. Results of glucose stimulation test at (A) day 1, (B) day 3, and (C) day 7. Islets cultured with HM-PA/K-PA nanofiber containing media preserved their insulin secretion
capability for 7 days better compared to other groups.
Fig. 4. Technique used to implant peptide amphiphile gel into the omentum of rats. The greater omentum was spread onto a sterile gauze pad and cargo (unless it was sham)
containing one PA gel, islet or their combination was placed onto it (A). The omentum was sutured like a pouch without disturbing the transplanted cargo (B). The Omentum
and stomach were placed back into the abdomen (C) and the abdomen was sutured (D).
G. Uzunalli et al. / Acta Biomaterialia 22 (2015) 8–18 13still increased at 90 min after glucose administration, followed by a
decrease after that point for both ‘‘control’’ and ‘‘islets transplanted
with PA scaffold’’ groups. However, the other experimental groups
did not show this blood glucose level pattern.
Although blood glucose levels typically start decreasing within
30 min in IPGT tests, no such trend was observed in our experi-
mental groups, except for a very slight decrease in the control
group. This was probably caused by the administration of general
anesthetics ketamycin and xylazine, which are known to interfere
with IPGTT results [50].
3.4. PA scaffold supports islet integrity and enhance vascular density of
the transplantation site
In order to monitor morphology of the transplanted islets on
day 28 post-transplantation, hematoxylin and eosin and Masson’strichrome stainings were carried out on omentum sections.
Hematoxylin and eosin staining revealed that ‘‘peptide gel only’’
transplanted group showed regular omentum morphology and
some peptide gel was still observable in the omentum
(Fig. 6A and B) although most of the gel was degraded by day 28.
The transplanted islets were observed to be in the group
where islets were transplanted with the PA gel, compared to the
only islet group which was more intact and had normal
morphology (Fig. 6C and D). This result shows that the PA gel helps
islets to maintain their integrity for up to 28 days.
Immunohistochemical staining showed that viable islets at the
transplantation site were positive for insulin, indicating that they
were still functioning on day 28 post-transplantation, and islets
transplanted with the PA gel were more intact (Fig. 6F–H).
Masson’s trichrome staining suggests that collagen is present in
the islets belonging to ‘‘only PA’’, ‘‘only islet’’ and ‘‘islets in PA
Fig. 5. (A) Blood glucose levels throughout 28 days (day 0; transplantation day) (B) intraperitoneal glucose tolerance test (IPGTT) at the end of 28 days.
Fig. 6. Hematoxylin and eosin (A–D), insulin immunohistochemical (E–H) and Masson’s trichrome (I–L) stainings of omenta after islet transplantation. (A–D) Islets
transplanted with PA gel conserved their morphology and integrity on post-transplantation day 28. (E–H) Islets transplanted with PA gel secrete insulin. (I–L) Masson’s
trichrome staining showed collagen expression around the transplantation site on post-transplantation day 28. Arrows show transplanted islets. All images were taken at
200 magnification. Scale bars are 100 lm.
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site (Fig. 6J–L).
Immunological response was visualized with macrophage
staining (Fig. S4). Macrophage presence was observed to be more
extensive around the islets in the ‘‘only islet’’ group compared to
the ‘‘islets in PA gel group’’ (Fig. S4).
In order to observe blood vessels in omenta, anti-von
Willebrand Factor staining was performed, as a vascular endothe-
lial cell marker (Fig. 7). Newly formed blood vessels within the PA
gel and islets were observed in ‘‘PA only’’, ‘‘islet only’’ and ‘‘islets in
PA gel’’ groups (Fig. 7B–D). We also assessed the number of intrao-
mental vascularization with 10 images per section and in a total of
5 sections from the omentum of each animal (Fig. 7E). This assess-
ment revealed ‘‘only PA’’ and ‘‘islets in PA gel’’ groups had a signif-
icantly more intraomental vessel number than those of other
groups. Additionally, there was a significant difference between
the sham group and groups containing PA (p < 0.001), which
demonstrate that PA itself promotes vascularization. The absence
of statistical difference between ‘‘sham’’ and ‘‘only islet’’ groups
and the presence of a statistical significant difference between
‘‘only islet’’ and ‘‘islet with PA groups’’ (p < 0.05) proved the fact
that increased vascularization was provided by HM-PA.Fig. 7. Immunohistochemical staining of blood vessels by using the von Willebrand Facto
from (A) sham, (B) PA hydrogel, (C) islet, (D) islet + PA hydrogel groups, and (E) average
100 lm.4. Discussion
Islet transplantation is currently the most promising therapeu-
tic method for diabetes treatment. Angiogenesis is crucial for via-
bility and functionality of islets after transplantation. In this
study, we utilized a bioactive peptide nanofiber system for enhanc-
ing viability and functionality of islets in vitro and in vivo. These
nanofibers are formed through the self-assembly of short peptide
amphiphile molecules (HM-PA) that were designed to mimic hep-
arin, since heparin is important in angiogenesis and growth factor
binding. HM-PA was previously shown to enhance angiogenesis
in vitro and in vivo through its interactions with heparin-binding
proangiogenic growth factors and their receptors [51]. In this work,
we used a positively charged peptide amphiphile, K-PA, which is
designed to induce nanofiber formation when mixed with nega-
tively charged HM-PA via electrostatic interactions and hydropho-
bic collapse at physiological pH [52]. Secondary structure
characterization proved that b-sheets drive the nanofiber forma-
tion (Fig. 1) [53].
Pancreatic islets are normally surrounded by ECM elements that
provide mechanical support and cellular signaling in the normal
pancreas. Because it affects the metabolic activity, it is importantr in the omenta and quantification of blood vessels. Representative sections obtained
blood vessel number. All images were taken at 200 magnification. Scale bars are
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conditions prior to the transplantation process [54]. Moreover, vas-
cular network integrity and cell–matrix interactions are dimin-
ished during isolation, resulting in a decrease in metabolic
function [55]. Thus, scaffolds and materials that can enhance islet
viability and function prior to and during the transplantation pro-
cess will be extremely valuable for the success of diabetes therapy.
While designing materials to mimic the natural ECM, it is impor-
tant not only to provide cells with the necessary mechanical sup-
port, but also to have enough porosity for diffusivity of required
components in the microenvironment. The natural nanofibers
comprising the ECM network are formed by glycosaminoglycans
and other fibrous and non-fibrous biomolecules [56]. In this study,
we utilized glycosaminoglycan mimetic peptide nanofiber scaf-
folds to provide the required support and retain islet shape with-
out causing any toxic effect (Fig. 2). In this way, cultured islets
maintained their glucose-responsive insulin secretion capability
to an extent comparable to freshly isolated islets. We observed
increased viability of cultured islets at days 1 and 3 when kept in
the HM-PA/K-PA combinations. The similarity between all experi-
mental groups at day 7 could have been caused by culturing in
serum-free media, since all in vitro experiments were performed
in serum-free conditions to eliminate external effects of serum,
which contains several growth factors, proteins and transcription
factors (Fig. 3) [48,57]. However, although the islets showed simi-
lar viability profiles between groups at day 7, the islets cultured in
HM-PA/K-PA nanofiber containing media showed a significant
enhancement of functionality compared to other groups, assessed
by glucose stimulation assay. The surprising similarity between
the responses of islets cultured in HM-PA/K-PA nanofiber contain-
ing media for 7 days and freshly isolated islets shows the effective-
ness of this nanofiber system for in vitro preservation of pancreatic
islets. Previously, it was shown that bioactive scaffolds such as col-
lagen, fibrin or fibronectin increase the insulin secretion of islets
[35,34]. In addition, when growth factor cocktails are added into
the system, islets can maintain their spherical morphology and
give the highest insulin secretion [33]. It is also known that islet
damage correlates with diminishing of insulin. Bennet et al.
showed that when islets were cultured with heparin, the islet dam-
age was reduced [58]. The success of our day 7 results may arise
because our system has both heparin mimetic bioactive peptide
scaffolds and growth factors. Encouraged by these in vitro findings,
our heparin mimetic gel system was analyzed for their effective-
ness as a scaffold system for islet transplantation in vivo.
The omental pouch model (Fig. 4) was used for transplantation
[59] since transplantation of islets to the omental site both protects
them from high blood pressure and provides large transplantation
volume [31]. After transplantation, islets transplanted within HM-
PA decreased blood glucose levels more than the ‘‘only islet’’ trans-
planted group (Fig. 5A). Furthermore, intraperitoneal blood glucose
tolerance tests performed 28 days after transplantation revealed
that ‘‘islets transplanted with PA gel’’ display a pattern similar to
the healthy control group; however, this pattern was not observed
in the sham group and ‘‘islet only’’ group (Fig. 5B).
Morphological analysis of the integrity of islets by hematoxylin
and eosin staining showed that ‘‘islets with PA gel’’ group pre-
served their original shape, while the ‘‘only islet’’ group did not.
Correlation between morphological integrity and functionality
was previously shown and the morphological integrity of the
transplanted islets might have contributed to better glucose
responsiveness of the ‘‘islets with PA gel’’ group [54].
Insulin positive cells were identified by immunohistochemistry
(IHC) in islet grafts transplanted both in the presence and the
absence of the PA gel, suggesting that the islets were functional
in vivo under both conditions. However, the number of insulin-
positive cells was strikingly enhanced in the presence of the PAgel (Fig. 6G and H). This result supports the conclusion that preser-
vation of islet integrity by the PA gel improves islet functionality
(insulin production) in vivo.
In healthy individuals, islets of Langerhans are surrounded by a
collagen matrix [54,60]. Collagen was deposited within implanted
PA gels, as demonstrated by IHC, whether or not islets were pre-
sent within the gel, but collagen deposition was not noted in
sham-operated or islet-only controls. This biological activity, colla-
gen deposition, might trigger the formation of an extracellular
matrix for the islets similar to the natural microenvironment after
transplantation and therefore could enhance transplantation effi-
ciency (Fig. 6J and L). Relatively fewer macrophages were present
around islets in the PA gel compared to the numbers of macro-
phages around islets alone, as demonstrated by IHC (Fig. S4).
Reduced macrophage infiltration after surgery might prevent
excess cell death, help to maintain islet integrity and functionality,
retain the insulin secretory capacity, and lower blood glucose
levels for a longer period. Implantation of the PA alone resulted
in a more intense immune response (macrophage infiltration) than
transplantation of islets in PA gel or transplantation of islets only.
This might have resulted because the release of various cytokines
from injured islets prevents macrophage recruitment to the
transplantation site [61–65].
Anti-von Willebrand staining was used to demonstrate vascu-
larization inside and around the islets, and in the omentum when
PA gel was applied or not (Fig. 7B–D). After blood vessel counting
and assessment for all animals in all groups, it was clarified that
the PA gel also promotes vascularization in vivo (Fig. 7E). The sig-
nificant difference between vessel numbers in islets without PA
compared to with PA may have been caused by the ability of
HM-PA to bind growth factors, concentrate them, and provide
them in excess amounts as previously shown [43,47]. In islet trans-
plantation, numbers of blood vessels in the transplantation site are
an important issue. In order to increase transplantation efficiency,
get a faster response to elevated glucose levels, and supply enough
oxygen and nutrients to the islets, a sufficient number of blood ves-
sels is required in the transplantation sides. Mammadov et al. pre-
viously showed that HM-PA enhances tube formation by
endothelial cells in vitro compared to Matrigel [47]. That provides
an explanation for our in vivo vascularization result, comparing
vessel numbers in the presence of the PA gel versus normal, non-
transplanted controls, and sham groups. With the PA gel system,
it was shown that vascularization in the omenta of animals can
be increased; and when this system is used with islets in trans-
plantation operation for T1D treatment, it increases the efficiency
and stabilizes blood glucose levels more effectively compared to
bare islet transplantation.5. Conclusion
In order to increase the islet transplantation efficiency, it is
important to maintain the required environment for survival and
function of islets both in vitro and in vivo. Herein, we presented a
bioactive peptide amphiphile nanofiber gel platform for islet cul-
ture and transplantation. Chemical and physiological characteriza-
tion studies of PAs showed that they can be used as synthetic ECM
mimicking agents with their nanofibrous structures. Our results
demonstrated that the PA gel provided a potent environment, dif-
fusion and mechanical support for viability and function of islets.
Under the serum-free condition, PA gel with the support of the
VEGF and FGF-2 provided GSI of fresh isolated islets even after
the 7 days of culture. These findings indicated that the PA gel can
be used for long-term culture of islets until the transplantation.
Furthermore, in vivo results indicated that islets transplanted with
PA scaffolds controlled blood glucose levels of STZ-induced
G. Uzunalli et al. / Acta Biomaterialia 22 (2015) 8–18 17diabetic rats more effectively than islets transplanted in the
absence of the PA gel. This finding showed that a supportive and
bioactive scaffold helps to increase transplantation efficiency.
Also, our histological analyses demonstrated that islets trans-
planted with the HM-PA gel were insulin positive for up to 28 days,
and vessel numbers were increased in groups containing the HM-
PA gel. These results may be explained by the affinity of the supra-
molecule HM-PA for growth factors which are key elements of
angiogenesis (VEGF and FGF2) and the ability of the HM-PA gel
to deliver them locally at the transplant site.Acknowledgements
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